141 related articles for article (PubMed ID: 19443354)
1. A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.
Sooriakumaran P; Coley HM; Fox SB; Macanas-Pirard P; Lovell DP; Henderson A; Eden CG; Miller PD; Langley SE; Laing RW
Anticancer Res; 2009 May; 29(5):1483-8. PubMed ID: 19443354
[TBL] [Abstract][Full Text] [Related]
2. A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.
Sooriakumaran P; Macanas-Pirard P; Bucca G; Henderson A; Langley SE; Laing RW; Smith CP; Laing EE; Coley HM
Cancer Genomics Proteomics; 2009; 6(2):93-9. PubMed ID: 19451093
[TBL] [Abstract][Full Text] [Related]
3. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
Narayanan BA; Narayanan NK; Pttman B; Reddy BS
Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
Cancer; 2007 Feb; 109(3):588-97. PubMed ID: 17177201
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.
Nery FG; Monkul ES; Hatch JP; Fonseca M; Zunta-Soares GB; Frey BN; Bowden CL; Soares JC
Hum Psychopharmacol; 2008 Mar; 23(2):87-94. PubMed ID: 18172906
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
Zheng X; Cui XX; Avila GE; Huang MT; Liu Y; Patel J; Kong AN; Paulino R; Shih WJ; Lin Y; Rabson AB; Reddy BS; Conney AH
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5480-7. PubMed ID: 17875778
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.
Sinsakul M; Sika M; Rodby R; Middleton J; Shyr Y; Chen H; Han E; Lehrich R; Clyne S; Schulman G; Harris R; Lewis J
Am J Kidney Dis; 2007 Dec; 50(6):946-51. PubMed ID: 18037095
[TBL] [Abstract][Full Text] [Related]
8. The effects of cyclooxygenase-2 expression in prostate cancer cells: modulation of response to cytotoxic agents.
Mehar A; Macanas-Pirard P; Mizokami A; Takahashi Y; Kass GE; Coley HM
J Pharmacol Exp Ther; 2008 Mar; 324(3):1181-7. PubMed ID: 18089846
[TBL] [Abstract][Full Text] [Related]
9. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
Narayanan BA; Reddy BS; Bosland MC; Nargi D; Horton L; Randolph C; Narayanan NK
Clin Cancer Res; 2007 Oct; 13(19):5965-73. PubMed ID: 17908994
[TBL] [Abstract][Full Text] [Related]
10. Pilot randomized phase II study of celecoxib in oral premalignant lesions.
Papadimitrakopoulou VA; William WN; Dannenberg AJ; Lippman SM; Lee JJ; Ondrey FG; Peterson DE; Feng L; Atwell A; El-Naggar AK; Nathan CO; Helman JI; Du B; Yueh B; Boyle JO
Clin Cancer Res; 2008 Apr; 14(7):2095-101. PubMed ID: 18381950
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study.
Falahatkar S; Mokhtari G; Pourreza F; Asgari SA; Kamran AN
Urology; 2008 Oct; 72(4):813-6. PubMed ID: 18692876
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxib.
Narayanan NK; Nargi D; Horton L; Reddy BS; Bosland MC; Narayanan BA
Prostate; 2009 Feb; 69(2):133-41. PubMed ID: 18819100
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib decreases Ki-67 proliferative index in active smokers.
Mao JT; Fishbein MC; Adams B; Roth MD; Goodglick L; Hong L; Burdick M; Strieter ER; Holmes C; Tashkin DP; Dubinett SM
Clin Cancer Res; 2006 Jan; 12(1):314-20. PubMed ID: 16397057
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
Daniels S; Robbins J; West CR; Nemeth MA
Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats.
Márquez-Rosado L; Trejo-Solís MC; García-Cuéllar CM; Villa-Treviño S
J Hepatol; 2005 Oct; 43(4):653-60. PubMed ID: 16023763
[TBL] [Abstract][Full Text] [Related]
16. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis.
Olivares C; Bilotas M; Buquet R; Borghi M; Sueldo C; Tesone M; Meresman G
Hum Reprod; 2008 Dec; 23(12):2701-8. PubMed ID: 18716040
[TBL] [Abstract][Full Text] [Related]
17. Combined action of celecoxib and ionizing radiation in prostate cancer cells is independent of pro-apoptotic Bax.
Handrick R; Ganswindt U; Faltin H; Goecke B; Daniel PT; Budach W; Belka C; Jendrossek V
Radiother Oncol; 2009 Mar; 90(3):413-21. PubMed ID: 19038466
[TBL] [Abstract][Full Text] [Related]
18. Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract.
Lai V; George J; Richey L; Kim HJ; Cannon T; Shores C; Couch M
Head Neck; 2008 Jan; 30(1):67-74. PubMed ID: 17615567
[TBL] [Abstract][Full Text] [Related]
19. [Chemopreventive effect of celecoxib against DMBA-induced breast cancer and its mechanism].
Kang HF; Wang XJ; Liu XX; Dai ZJ; Xue FJ; Xue XH
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1599-602. PubMed ID: 17121709
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib: new indication. Ankylosing spondylitis: no pain justifies the use of a cox-2 inhibitor. Patients still exposed to unjustified risks.
Prescrire Int; 2008 Jun; 17(95):106. PubMed ID: 18627117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
